Hazel Lote

2.8k total citations
17 papers, 198 citations indexed

About

Hazel Lote is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Hazel Lote has authored 17 papers receiving a total of 198 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 8 papers in Pulmonary and Respiratory Medicine and 7 papers in Surgery. Recurrent topics in Hazel Lote's work include Gastric Cancer Management and Outcomes (6 papers), HER2/EGFR in Cancer Research (4 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Hazel Lote is often cited by papers focused on Gastric Cancer Management and Outcomes (6 papers), HER2/EGFR in Cancer Research (4 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Hazel Lote collaborates with scholars based in United Kingdom, Sweden and Italy. Hazel Lote's co-authors include Ian Chau, Adam Sharp, Marta Capelán, Stefania Redana, Rille Pihlak, Vejay N. Vakharia, Marco Gerlinger, Naureen Starling, James Larkin and Aslam Sohaib and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Radiology.

In The Last Decade

Hazel Lote

16 papers receiving 195 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hazel Lote United Kingdom 8 116 78 39 37 30 17 198
Catherine Leyh Germany 6 78 0.7× 57 0.7× 64 1.6× 42 1.1× 33 1.1× 17 225
Myoung Won Son South Korea 10 101 0.9× 101 1.3× 61 1.6× 68 1.8× 47 1.6× 35 261
Jana Drozenová Czechia 8 66 0.6× 34 0.4× 23 0.6× 49 1.3× 19 0.6× 29 202
Anne Sibille Belgium 9 137 1.2× 83 1.1× 15 0.4× 53 1.4× 31 1.0× 21 204
Melike Özçelik Türkiye 10 95 0.8× 78 1.0× 45 1.2× 56 1.5× 11 0.4× 40 232
Changbo Sun China 11 99 0.9× 66 0.8× 73 1.9× 54 1.5× 18 0.6× 26 270
Haolin Yan China 10 97 0.8× 118 1.5× 109 2.8× 66 1.8× 18 0.6× 21 302
Yoko Zaitsu Japan 9 126 1.1× 74 0.9× 107 2.7× 37 1.0× 17 0.6× 30 257
Weigang Xiu China 9 122 1.1× 51 0.7× 31 0.8× 44 1.2× 20 0.7× 25 200
Miho Kawaida Japan 9 88 0.8× 100 1.3× 113 2.9× 45 1.2× 11 0.4× 33 262

Countries citing papers authored by Hazel Lote

Since Specialization
Citations

This map shows the geographic impact of Hazel Lote's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hazel Lote with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hazel Lote more than expected).

Fields of papers citing papers by Hazel Lote

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hazel Lote. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hazel Lote. The network helps show where Hazel Lote may publish in the future.

Co-authorship network of co-authors of Hazel Lote

This figure shows the co-authorship network connecting the top 25 collaborators of Hazel Lote. A scholar is included among the top collaborators of Hazel Lote based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hazel Lote. Hazel Lote is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Lote, Hazel & Ian Chau. (2024). Immunotherapy in Gastrointestinal Cancers. Cancer treatment and research. 192. 277–303. 2 indexed citations
2.
Lote, Hazel, Andrea Lampis, Ruwaida Begum, et al.. (2023). MicroRNAs as biomarkers for trastuzumab-based therapy in HER2-positive advanced oesophago-gastric cancer patients. Frontiers in Oncology. 13. 1258365–1258365. 2 indexed citations
3.
4.
Lote, Hazel, Naureen Starling, Rille Pihlak, & Marco Gerlinger. (2022). Advances in immunotherapy for MMR proficient colorectal cancer. Cancer Treatment Reviews. 111. 102480–102480. 18 indexed citations
5.
Lote, Hazel & Ian Chau. (2022). Emerging HER2-directed therapeutic agents for gastric cancer in early phase clinical trials. Expert Opinion on Investigational Drugs. 31(1). 59–78. 7 indexed citations
6.
Lote, Hazel, Andrea Lampis, Jens C. Hahne, et al.. (2020). Abstract 258: MicroRNAs as biomarkers of resistance to HER2 inhibition in combination with chemotherapy in gastro-esophageal cancer. Cancer Research. 80(16_Supplement). 258–258. 4 indexed citations
7.
Lote, Hazel, Nicola Valeri, & Ian Chau. (2018). HER2 inhibition in gastro-oesophageal cancer: A review drawing on lessons learned from breast cancer. World Journal of Gastrointestinal Oncology. 10(7). 159–171. 9 indexed citations
8.
Lote, Hazel, Domenico Zito, Rosemary Burke, et al.. (2016). MicroRNAs as biomarkers of resistance to HER2 inhibitors in combination with chemotherapy in gastro-oesophageal cancer cell lines. Annals of Oncology. 27. vi549–vi549. 1 indexed citations
9.
Sclafani, Francesco, Ian Chau, David Cunningham, et al.. (2016). KRAS mutations in circulating tumour DNA (ctDNA) in MRI-defined, high-risk, locally-advanced rectal cancer (LARC) patients (pts) from the EXPERT-C trial. Annals of Oncology. 27. vi173–vi173. 1 indexed citations
10.
Redana, Stefania, Adam Sharp, Hazel Lote, et al.. (2016). Rates of major complications during neoadjuvant and adjuvant chemotherapy for early breast cancer: An off study population. The Breast. 30. 13–18. 11 indexed citations
11.
Lote, Hazel, et al.. (2016). Febrile Neutropenia Rates According to Body Mass Index and Dose Capping in Women Receiving Chemotherapy for Early Breast Cancer. Clinical Oncology. 28(9). 597–603. 24 indexed citations
12.
Lote, Hazel, et al.. (2015). PD-1 and PD-L1 blockade in gastrointestinal malignancies. Cancer Treatment Reviews. 41(10). 893–903. 60 indexed citations
13.
Lote, Hazel, Jaishree Bhosle, Khin Thway, Kate Newbold, & Mary O’Brien. (2014). Epidermal Growth Factor Mutation as a Diagnostic and Therapeutic Target in Metastatic Poorly Differentiated Thyroid Carcinoma: A Case Report and Review of the Literature. Case Reports in Oncology. 7(2). 393–400. 8 indexed citations
14.
Thian, Yee Liang, Andreas Gutzeit, Dow‐Mu Koh, et al.. (2014). Revised Choi Imaging Criteria Correlate with Clinical Outcomes in Patients with Metastatic Renal Cell Carcinoma Treated with Sunitinib. Radiology. 273(2). 452–461. 28 indexed citations
15.
16.
Lote, Hazel, Geraint Fuller, & Peter G. Bain. (2013). 48, XXYY syndrome associated tremor. Practical Neurology. 13(4). 249–253. 7 indexed citations
17.
Vakharia, Vejay N. & Hazel Lote. (2012). Introduction of Sprotte needles to a single-centre acute neurology service: before and after study. JRSM Short Reports. 3(12). 1–5. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Catherine Leyh Breakdown of academic impact, for papers by Myoung Won Son Breakdown of academic impact, for papers by Jana Drozenová Breakdown of academic impact, for papers by Anne Sibille Breakdown of academic impact, for papers by Melike Özçelik Breakdown of academic impact, for papers by Changbo Sun Breakdown of academic impact, for papers by Haolin Yan Breakdown of academic impact, for papers by Yoko Zaitsu Breakdown of academic impact, for papers by Weigang Xiu Breakdown of academic impact, for papers by Miho Kawaida
Rankless by CCL
2026